Promega is a global leader in providing innovative solutions and scientific expertise that support the development of cell and gene therapies. With a broad portfolio of high-quality reagents and assays, Promega enables researchers and developers to generate reliable, meaningful data across the CGT workflow—from early research through process development, manufacturing, and quality control
Designed to address the complexity of living therapies, Promega’s cell and gene therapy solutions support critical measurements of cell health, identity, potency, safety, and functionality. Backed by deep technical support and a collaborative approach, Promega partners with the CGT community to help accelerate the delivery of transformative therapies to patients.